Angiogenex, Inc. (PC)
Ticker Symbol: USOTC:AGGX
OTC Market Tier: Pink Current
CIK Number: 0001085596
Security Type: Common Stock
AGGX Address: 425 Madison Ave
Ste 902
New York, New York 10017
AGGX Country: USA
AGGX Phone: (347) 468 6799
AGGX Fax #: N/A
Website: N/A
Description: Bio-Pharmaceutical Anti-Cancer Drug Development
SIC Code / Description: 2834 / Pharmaceutical preparations
Shares Authorized:
Shares Outstanding: 30,386,667
Shares Outstanding Date: 03/27/2019
Shares Holder Count: 220
Shares Holder Date: 04/02/2018
Market Capitalization: $ 7,292,800.08
Key Executives: William Garland - CEO
Number of Employees: N/A
Incorporation State: NV
Incorporation Country: USA
Incorporation Year: N/A
Auditor: N/A
IR Firm: N/A
Legal Counsel: N/A
Fiscal Year End: 12/31
Reporting Status: SEC Reporting
Bankrupt: No
Shell: No
Audit Status: No
ADR Ratio: N/A
Transfer Agent: N/A
Depository Website: N/A
SHO Flag: N/A
3210 Flag: N/A
Short Volume: 88
Short Date: 04/15/2019
Closing MMID: 5
BFCMmid: 3
Tier ID: 20
Status: Active


Your Recent History
USOTC
AGGX
Angiogenex..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.